Google
OSTX 株価分析 — Os Therapies Incorporated (Healthcare >> Biotechnology)
OSTX に関するよくある質問
OSTXのROE（自己資本利益率）は？
Os Therapies IncorporatedのROEは325.88%です。
OSTXの配当利回りは？
Os Therapies Incorporatedの配当利回りは0.00%です。
OSTXの品質スコア（Quality Score）は？
当社のAIはOSTXの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
OSTXは今が買い時ですか？
当社AIのタイミングスコアは100点中28点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
OSTXはどのセクターに属しますか？
Os Therapies IncorporatedはHealthcare >> Biotechnologyセクターに分類されます（NYSE MKT市場）
OSTX AI Analysis Summary
Our AI summary for OSTX: Os Therapies Incorporated (NYSE MKT), Healthcare >> Biotechnology sector. The stock currently trades at ROE of 325.88%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 28/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 1.63
Price
0.08
(5.16%)
Day Change
|
|
|---|
OSTX, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.63 |
| PBV / Sector |
-6.52 / 44,022.72
|
| Earning Per Share | -0.81 |
| PE / Sector |
N/A / 19.17
|
| PEG or PE/Growth / Sector |
N/A / 1.24
|
| Average 1M Daily Value |
0.75 M
GREAT
|
| Average 1W Daily Value |
0.43 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-08-05 08:00:39 |
| Symbol | OSTX |
| Name | OS THERAPIES INCORPORATED |
| Sector | Healthcare >> Biotechnology |
| Market | NYSE MKT |
| Listed Shares | 45.54 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 70.58 / 9,586.08 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 115 Pullman Crossing Road, Grasonville, MD, United States, 21638
Phone: 410 297 7793
Website: https://ostherapies.com
Sector: Healthcare >> Biotechnology
Description: OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
